Export

EN
FR
Levodopa + carbidopa
Essential medicine status
Section:
5. Medicines for diseases of the nervous system 5.3. Medicines for parkinsonism
ATC codes: N04BA02
Indication
Parkinson disease ICD11 code: 8A00.0Z
INN
Levodopa + carbidopa
Medicine type
Chemical agent
List type
Core
Formulations
Oral > Solid: 100 mg + 10 mg tablet ; 250 mg + 25 mg tablet ; 100 mg + 25 mg tablet
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1982 (TRS 685)
Changed in 2003 (TRS 920)
Changed in 2013 (TRS 985)
Changed in 2021 (TRS 1035)
Sex
All
Age
Adolescents and adults
Therapeutic alternatives
levodopa + benserazide (ATC codes: N04BA02)
Patent information
Patents have expired in most jurisdictions
Wikipedia
Levodopa + carbidopa
DrugBank
Levodopa ,
Carbidopa
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee recommended benserazide be specified as a therapeutic alternative for the carbidopa component under the square box listing for levodopa + carbidopa on the EML.